FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 166 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Aumolertinib FDA Approves Niraparib and Abiraterone Acetate Plus Prednisone for BRCA2-mutated Metastatic Castration-Sensitive Prostate Cancer The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights of Patients with Cancer via Cross-Border Best Practices and Collaboration MOST POPULAR Breast Cancer Death Rates Will Rise in Elderly EU Patients but... March 12, 2025 2-Time Cancer Survivor Warns Against Breast Implants After 4 Doctors Missed... June 25, 2019 Health inequalities: Why do people smoke if they know it’s bad... April 1, 2022 Study Suggests a Link between Stress and Cancer Coming Back January 14, 2021 Load more HOT NEWS EMA Recommends Granting a Marketing Authorisation for Sacituzumab Govitecan Qué deben saber los latinos sobre dejar de fumar y las... A Clinical Signal of Efficacy Observed with a Combination of Nivolumab... Charity promotes eco-fashion with collection at Love Not Landfill pop-up
